As of 2025-03-16, the Relative Valuation of Maravai LifeSciences Holdings Inc (MRVI) is 14.06 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.45 USD, the upside of Maravai LifeSciences Holdings Inc based on Relative Valuation is 473.9%.
The range of the Relative Valuation is (26.74) - 61.55 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.1x - 34.3x | 31.1x |
| Forward P/E multiples | 26.1x - 29.9x | 27.1x |
| Fair Price | (26.74) - 61.55 | 14.06 |
| Upside | -1191.5% - 2412.4% | 473.9% |
| Date | P/E |
| 2025-03-14 | -2.75 |
| 2025-03-13 | -2.72 |
| 2025-03-12 | -2.93 |
| 2025-03-11 | -2.97 |
| 2025-03-10 | -3.21 |
| 2025-03-07 | -3.33 |
| 2025-03-06 | -3.00 |
| 2025-03-05 | -3.16 |
| 2025-03-04 | -3.19 |
| 2025-03-03 | -3.39 |
| 2025-02-28 | -3.62 |
| 2025-02-27 | -3.43 |
| 2025-02-26 | -3.65 |
| 2025-02-25 | -3.53 |
| 2025-02-24 | -4.51 |
| 2025-02-21 | -4.62 |
| 2025-02-20 | -4.44 |
| 2025-02-19 | -4.59 |
| 2025-02-18 | -4.61 |
| 2025-02-14 | -4.72 |
| 2025-02-13 | -4.63 |
| 2025-02-12 | -4.79 |
| 2025-02-11 | -4.77 |
| 2025-02-10 | -4.83 |
| 2025-02-07 | -5.15 |
| 2025-02-06 | -5.56 |
| 2025-02-05 | -5.55 |
| 2025-02-04 | -5.36 |
| 2025-02-03 | -5.55 |
| 2025-01-31 | -5.54 |
| 2025-01-30 | -5.68 |
| 2025-01-29 | -5.65 |
| 2025-01-28 | -6.18 |
| 2025-01-27 | -6.31 |
| 2025-01-24 | -6.32 |
| 2025-01-23 | -6.33 |
| 2025-01-22 | -5.98 |
| 2025-01-21 | -5.88 |
| 2025-01-17 | -5.36 |
| 2025-01-16 | -5.14 |
| 2025-01-15 | -5.13 |
| 2025-01-14 | -5.10 |
| 2025-01-13 | -5.55 |
| 2025-01-10 | -5.45 |
| 2025-01-08 | -6.89 |
| 2025-01-07 | -6.80 |
| 2025-01-06 | -6.69 |
| 2025-01-03 | -6.38 |
| 2025-01-02 | -6.17 |
| 2024-12-31 | -6.13 |